Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer
Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer
Recruiting · NCT07689851 · Registry updated 2026-07-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, gastroesophageal junction adenocarcinoma, neoplasm, stomach disorder | Recruiting | Phase 2 | 2026-07-08 | NCT07689851 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 294 |
| Jiangsu Hengrui Pharmaceutical Co., Ltd. | 29 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences Shenzhen Hospital | Shenzhen | China | 1 |
| National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College | Beijing | China | 6 |
| Shanxi Cancer Hospital | Taiyuan | China | 25 |